G1 Therapeutics Inc. (GTHX) NASDAQ

$7.43 -0.48 (-6.07%)

Market Cap: $339.43M

As of 02/06/23 04:00 PM EST. Market closed.

(GTHX)

G1 Therapeutics Inc. (GTHX) NASDAQ

$7.43 -0.48 (-6.07%)

Market Cap: $339.43M

As of 02/06/23 04:00 PM EST. Market closed.

G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development and delivery of next generation therapies that improve the lives of those affected by cancer, including the Company's first commercial product, COSELA™ (trilaciclib). G1 has a deep clinical pipeline evaluating targeted cancer therapies in a variety of solid tumors, including colorectal, ... read more

G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development and delivery of next generation therapies that improve the lives of those affected by cancer, including the Company's first commercial product, COSELA™ (trilaciclib). G1 has a deep clinical pipeline evaluating targeted cancer therapies in a variety of solid tumors, including colorectal, breast, lung, and bladder cancers. G1 Therapeutics is based in Research Triangle Park, N.C. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Mark Velleca
Full Time Employees
148
CEO Compensation (Base)
$515,000
CEO Compensation (Total)
$1.91M
URL
Address
700 Park Offices Drive, Suite 200, North Carolina, Research Triangle Park, 27709.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Mark Velleca
Full Time Employees
148
CEO Compensation (Base)
$515,000
CEO Compensation (Total)
$1.91M
Address
700 Park Offices Drive, Suite 200, North Carolina, Research Triangle Park, 27709.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$7.66
Previous Close
$7.91
Days Range
$7.43 - $7.84
52 week range
$3.84 - $17.49
Volume
626,479
Avg. Volume (30 days)
969,376
Market Cap
$339.43M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
42,912,081
Open
$7.66
Previous Close
$7.91
Days Range
$7.43 - $7.84
52 week range
$3.84 - $17.49
Volume
626,479
Avg. Volume (30 days)
969,376
Market Cap
$339.43M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
42,912,081

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR G1 THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Moses Jennifer K.CFOJan 05, 2023 Sale$5.417293,94257,820Jan 05, 2023, 08:26 PM
Moses Jennifer K.CFOJan 04, 2023 Sale$5.581,6399,13858,549Jan 05, 2023, 08:26 PM
MURDOCK TERRY LChief Operating OfficerJan 05, 2023 Sale$5.417293,94236,439Jan 05, 2023, 08:26 PM
MURDOCK TERRY LChief Operating OfficerJan 04, 2023 Sale$5.581,6399,13837,168Jan 05, 2023, 08:26 PM
Perry AndrewChief Commercial OfficerJan 04, 2023 Sale$5.588204,57221,300Jan 05, 2023, 08:25 PM
Malik RajeshChief Medical OfficerJan 05, 2023 Sale$5.417293,942102,739Jan 05, 2023, 08:25 PM
Malik RajeshChief Medical OfficerJan 04, 2023 Sale$5.581,6399,138103,468Jan 05, 2023, 08:25 PM
Hanson James S.General CounselJan 05, 2023 Sale$5.417293,94241,087Jan 05, 2023, 08:25 PM
Hanson James S.General CounselJan 04, 2023 Sale$5.581,6399,13841,816Jan 05, 2023, 08:25 PM
Bailey John E. (Jack) Jr.President and CEOJan 04, 2023 Sale$5.585,60731,262276,282Jan 05, 2023, 08:23 PM
Bailey John E. (Jack) Jr.President and CEOJan 03, 2023 Sale$5.8532,019187,452281,889Jan 05, 2023, 08:23 PM
Malik RajeshChief Medical OfficerDec 15, 2022 Option Exercise$0.3014,0004,20087,207Dec 16, 2022, 04:12 PM
Velleca Mark A.DirectorOct 18, 2022 Option Exercise$0.3915,0005,850131,000Oct 20, 2022, 04:05 PM
Velleca Mark A.DirectorOct 18, 2022 Sale$11.7015,000175,489116,000Oct 20, 2022, 04:05 PM
Velleca Mark A.DirectorSep 20, 2022 Option Exercise$0.3920,0007,800136,000Sep 22, 2022, 04:40 PM
Velleca Mark A.DirectorSep 20, 2022 Sale$13.5020,000270,044116,000Sep 22, 2022, 04:40 PM
Malik RajeshChief Medical OfficerSep 13, 2022 Option Exercise$0.3918,0007,02091,207Sep 16, 2022, 04:31 PM
Malik RajeshChief Medical OfficerSep 13, 2022 Sale$15.7118,000282,74673,207Sep 16, 2022, 04:31 PM
Velleca Mark A.DirectorAug 16, 2022 Option Exercise$0.3980,00031,200196,000Aug 18, 2022, 04:06 PM
Velleca Mark A.DirectorAug 16, 2022 Sale$12.6480,0001,010,904116,000Aug 18, 2022, 04:06 PM
Velleca Mark A.DirectorFeb 07, 2022 Option Exercise$0.3915,0005,850116,000Feb 08, 2022, 04:05 PM
Moses Jennifer K.CFOFeb 01, 2022 Option Exercise$4.112,3339,57937,888Feb 02, 2022, 05:20 PM
Malik RajeshChief Medical OfficerFeb 01, 2022 Option Exercise$0.3010,0003,00073,855Feb 02, 2022, 05:20 PM
Hanson James S.General CounselJan 05, 2022 Sale$10.611,44515,33425,555Jan 05, 2022, 08:48 PM
MURDOCK TERRY LChief Operating OfficerJan 05, 2022 Sale$10.611,44515,33421,555Jan 05, 2022, 08:25 PM
Moses Jennifer K.CFOJan 05, 2022 Sale$10.611,44515,33435,555Jan 05, 2022, 08:25 PM
Malik RajeshChief Medical OfficerJan 05, 2022 Sale$10.611,44515,33463,855Jan 05, 2022, 08:24 PM
Avagliano MarkChief Business OfficerJan 05, 2022 Sale$10.611,44515,33421,555Jan 05, 2022, 08:24 PM
Bailey John E. (Jack) Jr.President and CEOJan 03, 2022 Sale$10.4134,125355,262233,208Jan 05, 2022, 08:24 PM
Velleca Mark A.DirectorNov 09, 2021 Option Exercise$0.3940,00015,600101,000Nov 10, 2021, 04:05 PM
Velleca Mark A.DirectorJul 15, 2021 Option Exercise$0.3910,0003,90071,000Jul 15, 2021, 04:01 PM
Velleca Mark A.DirectorJul 14, 2021 Option Exercise$0.3910,0003,90071,000Jul 15, 2021, 04:01 PM
Velleca Mark A.DirectorJul 13, 2021 Option Exercise$0.3910,0003,90071,000Jul 15, 2021, 04:01 PM
Velleca Mark A.DirectorJul 14, 2021 Sale$19.0810,000190,82461,000Jul 15, 2021, 04:01 PM
Velleca Mark A.DirectorJul 13, 2021 Sale$19.4510,000194,53661,000Jul 15, 2021, 04:01 PM
Velleca Mark A.DirectorJul 15, 2021 Sale$18.4910,000184,89861,000Jul 15, 2021, 04:01 PM
RUDNICK SETHDirectorJun 29, 2021 Option Exercise$0.3710,0003,71714,389Jun 30, 2021, 04:05 PM
RUDNICK SETHDirectorJun 29, 2021 Sale$22.3510,000223,4774,389Jun 30, 2021, 04:05 PM
Velleca Mark A.DirectorJun 17, 2021 Option Exercise$0.3910,0003,90071,000Jun 17, 2021, 04:05 PM
Velleca Mark A.DirectorJun 16, 2021 Option Exercise$0.3910,0003,90071,000Jun 17, 2021, 04:05 PM
Velleca Mark A.DirectorJun 15, 2021 Option Exercise$0.3910,0003,90071,000Jun 17, 2021, 04:05 PM
Velleca Mark A.DirectorJun 17, 2021 Sale$21.7710,000217,72861,000Jun 17, 2021, 04:05 PM
Velleca Mark A.DirectorJun 16, 2021 Sale$21.7410,000217,38461,000Jun 17, 2021, 04:05 PM
Velleca Mark A.DirectorJun 15, 2021 Sale$22.3910,000223,90961,000Jun 17, 2021, 04:05 PM
Velleca Mark A.DirectorMay 25, 2021 Option Exercise$0.3920,0007,80061,000May 25, 2021, 06:29 PM
Malik RajeshChief Medical OfficerApr 22, 2021 Option Exercise$0.3915,0005,85058,300Apr 23, 2021, 04:39 PM
Malik RajeshChief Medical OfficerApr 22, 2021 Sale$22.0715,000331,09943,300Apr 23, 2021, 04:39 PM
Malik RajeshChief Medical OfficerMar 23, 2021 Option Exercise$0.3915,0005,85058,300Mar 24, 2021, 04:47 PM
Malik RajeshChief Medical OfficerMar 23, 2021 Sale$21.9415,000329,05943,300Mar 24, 2021, 04:47 PM
Malik RajeshChief Medical OfficerMar 02, 2021 Option Exercise$1.5515,00023,21958,300Mar 04, 2021, 05:10 PM
Malik RajeshChief Medical OfficerMar 02, 2021 Sale$22.9515,000344,19243,300Mar 04, 2021, 05:10 PM
Moses Jennifer K.CFOMar 03, 2021 Option Exercise$3.723,00011,16025,000Mar 04, 2021, 04:54 PM
Velleca Mark A.DirectorFeb 16, 2021 Option Exercise$3.7211,04041,06952,040Feb 18, 2021, 05:49 PM
Velleca Mark A.DirectorFeb 18, 2021 Option Exercise$3.7210,00037,20051,000Feb 18, 2021, 05:49 PM
Velleca Mark A.DirectorFeb 17, 2021 Option Exercise$3.7210,00037,20051,000Feb 18, 2021, 05:49 PM
Velleca Mark A.DirectorFeb 16, 2021 Sale$35.2011,040388,65343,723Feb 18, 2021, 05:49 PM
Velleca Mark A.DirectorFeb 18, 2021 Sale$26.0210,000260,15241,000Feb 18, 2021, 05:49 PM
Velleca Mark A.DirectorFeb 17, 2021 Sale$27.6410,000276,43341,600Feb 18, 2021, 05:49 PM
Malik RajeshChief Medical OfficerJan 27, 2021 Option Exercise$0.393,1001,20943,300Jan 29, 2021, 04:07 PM
Malik RajeshChief Medical OfficerJan 22, 2021 Option Exercise$4.1715,00062,55055,200Jan 22, 2021, 06:47 PM
Malik RajeshChief Medical OfficerJan 22, 2021 Sale$20.6415,000309,59140,200Jan 22, 2021, 06:47 PM
Velleca Mark A.DirectorJan 20, 2021 Option Exercise$2.7714,00038,76047,000Jan 21, 2021, 05:31 PM
Velleca Mark A.DirectorJan 19, 2021 Option Exercise$3.7210,00037,20047,000Jan 21, 2021, 05:31 PM
Velleca Mark A.DirectorJan 21, 2021 Option Exercise$3.7210,00037,20051,000Jan 21, 2021, 05:31 PM
Velleca Mark A.DirectorJan 20, 2021 Sale$21.5110,000215,10737,000Jan 21, 2021, 05:31 PM
Velleca Mark A.DirectorJan 19, 2021 Sale$20.8810,000208,78137,000Jan 21, 2021, 05:31 PM
Velleca Mark A.DirectorJan 21, 2021 Sale$20.6410,000206,40041,000Jan 21, 2021, 05:31 PM
RUDNICK SETHDirectorDec 24, 2020 Sale$20.1092418,5725,266Dec 29, 2020, 04:50 PM
RUDNICK SETHDirectorDec 22, 2020 Sale$20.3318,974385,70219,308Dec 23, 2020, 06:54 PM
RUDNICK SETHDirectorDec 23, 2020 Sale$20.1813,118264,7576,190Dec 23, 2020, 06:54 PM
Velleca Mark A.President and CEODec 17, 2020 Option Exercise$3.7210,00037,20047,000Dec 17, 2020, 06:01 PM
Velleca Mark A.President and CEODec 16, 2020 Option Exercise$3.7210,00037,20047,000Dec 17, 2020, 06:01 PM
Velleca Mark A.President and CEODec 15, 2020 Option Exercise$3.7210,00037,20047,000Dec 17, 2020, 06:01 PM
Velleca Mark A.President and CEODec 17, 2020 Sale$19.9710,000199,66837,000Dec 17, 2020, 06:01 PM
Velleca Mark A.President and CEODec 16, 2020 Sale$19.2010,000192,02137,000Dec 17, 2020, 06:01 PM
Velleca Mark A.President and CEODec 15, 2020 Sale$19.4310,000194,29737,000Dec 17, 2020, 06:01 PM
Malik RajeshCh. Medical Officer & SVP R&DDec 10, 2020 Option Exercise$4.179,00037,53038,200Dec 11, 2020, 04:50 PM
Malik RajeshCh. Medical Officer & SVP R&DDec 10, 2020 Sale$20.069,000180,55029,200Dec 11, 2020, 04:50 PM
RUDNICK SETHDirectorDec 10, 2020 Sale$20.0054610,92138,282Dec 10, 2020, 05:30 PM
RUDNICK SETHDirectorDec 09, 2020 Sale$20.325,773117,28438,828Dec 10, 2020, 05:30 PM
RUDNICK SETHDirectorDec 08, 2020 Sale$20.1913,161265,69444,601Dec 10, 2020, 05:30 PM
RUDNICK SETHDirectorDec 01, 2020 Sale$20.0952010,44957,762Dec 03, 2020, 04:20 PM
MUIR GLENN PDirectorNov 18, 2020 Buy$13.5050,000675,000170,969Nov 19, 2020, 04:54 PM
Bailey John E. (Jack) Jr.DirectorNov 11, 2020 Buy$12.834,00051,3208,000Nov 13, 2020, 04:33 PM
Bailey John E. (Jack) Jr.DirectorNov 10, 2020 Buy$12.764,00051,0554,000Nov 13, 2020, 04:33 PM
Hanson James S.General CounselSep 04, 2020 Buy$14.951,00014,9504,000Sep 08, 2020, 08:38 PM
Moses Jennifer K.CFOMar 13, 2020 Option Exercise$3.722,0007,44011,000Mar 16, 2020, 07:00 AM
Malik RajeshCh. Medical Officer & SVP R&DMar 13, 2020 Option Exercise$0.392,50097529,200Mar 16, 2020, 07:00 AM
Velleca Mark A.President and CEOMar 13, 2020 Option Exercise$0.393,0001,17037,000Mar 16, 2020, 07:00 AM
Velleca Mark A.President and CEOJan 23, 2020 Option Exercise$0.396,0002,34034,000Jan 24, 2020, 04:59 PM
Moses Jennifer K.CFOJan 23, 2020 Option Exercise$3.721,0003,7209,000Jan 24, 2020, 04:58 PM
Malik RajeshCh. Medical Officer & SVP R&DJan 23, 2020 Option Exercise$0.395,0001,95026,700Jan 24, 2020, 04:58 PM
Moses Jennifer K.CFOJul 18, 2019 Option Exercise$3.722,0007,4408,000Jul 19, 2019, 09:58 PM
Malik RajeshCh. Medical Officer & SVP R&DJan 28, 2019 Option Exercise$0.397,0002,73021,700Jan 28, 2019, 09:10 PM
Moses Jennifer K.VP of FinanceJan 17, 2019 Option Exercise$3.722,0007,4406,000Jan 17, 2019, 05:52 PM
Velleca Mark A.President and CEOJan 17, 2019 Option Exercise$0.399,0003,51028,000Jan 17, 2019, 05:52 PM
Strum JayChief Scientific OfficerJan 02, 2019 Option Exercise$0.3579,81827,575129,237Jan 02, 2019, 05:46 PM
Hanson James S.General CounselDec 26, 2018 Buy$18.251,00018,2503,000Dec 27, 2018, 04:59 PM
Schwalm CynthiaDirectorDec 26, 2018 Buy$18.451,42026,1961,500Dec 27, 2018, 04:59 PM
Malik RajeshCh. Medical Officer & SVP R&DDec 17, 2018 Option Exercise$4.173,77615,74618,476Dec 17, 2018, 04:27 PM
Malik RajeshCh. Medical Officer & SVP R&DDec 17, 2018 Sale$30.003,776113,28014,700Dec 17, 2018, 04:27 PM
Hanson James S.General CounselDec 10, 2018 Buy$32.511,00032,5082,000Dec 11, 2018, 04:08 PM
DEMAREE JOHNChief Commercial OfficerDec 10, 2018 Buy$33.151,00033,1515,250Dec 11, 2018, 04:08 PM
Moses Jennifer K.VP of Finance & AdminDec 07, 2018 Option Exercise$3.722,0007,4404,000Dec 07, 2018, 04:07 PM
Moses Jennifer K.VP of Finance & AdminDec 06, 2018 Option Exercise$0.397502922,750Dec 07, 2018, 04:07 PM
Moses Jennifer K.VP of Finance & AdminDec 06, 2018 Sale$34.0075025,5002,000Dec 07, 2018, 04:07 PM
RUDNICK SETHDirectorDec 04, 2018 Option Exercise$0.3910,0003,90010,000Dec 04, 2018, 06:10 PM
RUDNICK SETHDirectorDec 04, 2018 Sale$39.3110,000393,146116Dec 04, 2018, 06:10 PM
MURDOCK TERRY LSVP of Development OperationsDec 03, 2018 Option Exercise$13.513,52347,5963,523Dec 03, 2018, 06:25 PM
MURDOCK TERRY LSVP of Development OperationsDec 03, 2018 Sale$38.543,523135,7790Dec 03, 2018, 06:25 PM
PHILLIPS BARCLAY ASVP & Chief Financial OfficerNov 15, 2018 Option Exercise$19.465,00097,3005,000Nov 16, 2018, 07:16 PM
PHILLIPS BARCLAY ASVP & Chief Financial OfficerNov 15, 2018 Sale$39.925,000199,5910Nov 16, 2018, 07:16 PM
Velleca Mark A.President and CEONov 15, 2018 Option Exercise$3.725,00018,60024,000Nov 16, 2018, 05:17 PM
Velleca Mark A.President and CEONov 15, 2018 Sale$39.845,000199,21119,015Nov 16, 2018, 05:17 PM
Malik RajeshCh. Medical Officer & SVP R&DNov 15, 2018 Option Exercise$4.173,77615,74618,476Nov 16, 2018, 05:17 PM
Malik RajeshCh. Medical Officer & SVP R&DNov 15, 2018 Sale$39.753,776150,10514,947Nov 16, 2018, 05:17 PM
RUDNICK SETHDirectorNov 05, 2018 Option Exercise$0.3910,0003,90010,000Nov 07, 2018, 06:18 PM
RUDNICK SETHDirectorNov 05, 2018 Sale$41.5310,000415,3470Nov 07, 2018, 06:18 PM
MURDOCK TERRY LSVP of Development OperationsNov 05, 2018 Option Exercise$13.513,51947,5423,519Nov 07, 2018, 06:18 PM
MURDOCK TERRY LSVP of Development OperationsNov 05, 2018 Sale$41.533,519146,1290Nov 07, 2018, 06:18 PM
Moses Jennifer K.VP of Finance & AdminNov 05, 2018 Option Exercise$0.397502922,750Nov 07, 2018, 06:15 PM
Moses Jennifer K.VP of Finance & AdminNov 05, 2018 Sale$41.3875031,0352,000Nov 07, 2018, 06:15 PM
Malik RajeshCh. Medical Officer & SVP R&DOct 15, 2018 Option Exercise$1.8110,07618,20314,700Oct 15, 2018, 05:57 PM
Malik RajeshCh. Medical Officer & SVP R&DOct 15, 2018 Sale$41.713,776157,49711,233Oct 15, 2018, 05:57 PM
Velleca Mark A.President and CEOOct 11, 2018 Option Exercise$0.3910,0003,90019,000Oct 15, 2018, 05:54 PM
Velleca Mark A.President and CEOOct 15, 2018 Option Exercise$3.725,00018,60024,000Oct 15, 2018, 05:54 PM
Velleca Mark A.President and CEOOct 15, 2018 Sale$41.535,000207,64521,837Oct 15, 2018, 05:54 PM
Moses Jennifer K.VP of Finance & AdminOct 08, 2018 Option Exercise$0.397502922,750Oct 10, 2018, 04:45 PM
Moses Jennifer K.VP of Finance & AdminOct 08, 2018 Sale$44.5275033,3902,000Oct 10, 2018, 04:45 PM
Strum JayChief Scientific OfficerOct 04, 2018 Option Exercise$0.3085025549,419Oct 05, 2018, 06:04 PM
RUDNICK SETHDirectorOct 04, 2018 Option Exercise$0.3910,0003,90010,000Oct 05, 2018, 06:02 PM
RUDNICK SETHDirectorOct 04, 2018 Sale$49.7210,000497,2101,980Oct 05, 2018, 06:02 PM
MURDOCK TERRY LSVP of Development OperationsOct 03, 2018 Option Exercise$13.513,51947,5423,519Oct 05, 2018, 06:02 PM
MURDOCK TERRY LSVP of Development OperationsOct 03, 2018 Sale$49.183,519173,0640Oct 05, 2018, 06:02 PM
Velleca Mark A.President and CEOSep 17, 2018 Option Exercise$3.725,00018,60014,000Sep 19, 2018, 07:08 PM
Velleca Mark A.President and CEOSep 17, 2018 Sale$66.315,000331,54911,165Sep 19, 2018, 07:08 PM
Malik RajeshCh. Medical Officer & SVP R&DSep 17, 2018 Option Exercise$4.173,77615,74612,176Sep 19, 2018, 07:07 PM
Malik RajeshCh. Medical Officer & SVP R&DSep 17, 2018 Sale$66.083,776249,5029,184Sep 19, 2018, 07:07 PM
Moses Jennifer K.VP of Finance & AdminSep 05, 2018 Option Exercise$2.812,7507,7332,000Sep 06, 2018, 04:07 PM
Moses Jennifer K.VP of Finance & AdminSep 05, 2018 Sale$59.6075044,7000Sep 06, 2018, 04:07 PM
RUDNICK SETHDirectorSep 04, 2018 Option Exercise$0.3910,0003,90010,000Sep 06, 2018, 04:07 PM
RUDNICK SETHDirectorSep 04, 2018 Sale$59.9510,000599,483500Sep 06, 2018, 04:07 PM
MURDOCK TERRY LSVP of Development OperationsSep 04, 2018 Option Exercise$13.513,51947,5423,519Sep 06, 2018, 04:06 PM
MURDOCK TERRY LSVP of Development OperationsSep 04, 2018 Sale$59.983,519211,0650Sep 06, 2018, 04:06 PM
Strum JayChief Scientific OfficerAug 30, 2018 Sale$59.985,000299,87653,069Aug 31, 2018, 04:20 PM
Strum JayChief Scientific OfficerAug 29, 2018 Sale$59.225,000296,09557,969Aug 31, 2018, 04:20 PM
Malik RajeshCh. Medical Officer & SVP R&DAug 15, 2018 Option Exercise$4.173,77615,74612,176Aug 17, 2018, 03:00 PM
Malik RajeshCh. Medical Officer & SVP R&DAug 15, 2018 Sale$55.893,776211,02310,100Aug 17, 2018, 03:00 PM
Velleca Mark A.President and CEOAug 15, 2018 Option Exercise$3.725,00018,60014,000Aug 17, 2018, 02:59 PM
Velleca Mark A.President and CEOAug 15, 2018 Sale$55.885,000279,37811,301Aug 17, 2018, 02:59 PM
RUDNICK SETHDirectorAug 06, 2018 Option Exercise$0.3910,0003,90010,000Aug 06, 2018, 06:19 PM
RUDNICK SETHDirectorAug 06, 2018 Sale$50.6910,000506,9010Aug 06, 2018, 06:19 PM
Moses Jennifer K.VP of Finance & AdminAug 06, 2018 Option Exercise$0.39750292750Aug 06, 2018, 06:18 PM
Moses Jennifer K.VP of Finance & AdminAug 06, 2018 Sale$50.7975038,0930Aug 06, 2018, 06:18 PM
MURDOCK TERRY LSVP of Development OperationsAug 03, 2018 Option Exercise$13.513,51947,5423,519Aug 06, 2018, 06:17 PM
MURDOCK TERRY LSVP of Development OperationsAug 03, 2018 Sale$50.603,519178,0610Aug 06, 2018, 06:17 PM
Malik RajeshCh. Medical Officer & SVP R&DJul 16, 2018 Option Exercise$4.173,77615,74612,176Jul 17, 2018, 04:01 PM
Malik RajeshCh. Medical Officer & SVP R&DJul 16, 2018 Sale$42.173,776159,2489,662Jul 17, 2018, 04:01 PM
Velleca Mark A.President and CEOJul 16, 2018 Option Exercise$3.725,00018,60014,000Jul 17, 2018, 04:01 PM
Velleca Mark A.President and CEOJul 16, 2018 Sale$42.065,000210,31310,200Jul 17, 2018, 04:01 PM
Moses Jennifer K.VP of Finance & AdminJul 05, 2018 Option Exercise$0.39750292750Jul 05, 2018, 03:21 PM
Moses Jennifer K.VP of Finance & AdminJul 05, 2018 Sale$45.6675034,2450Jul 05, 2018, 03:21 PM
Malik RajeshCh. Medical Officer & SVP R&DJun 15, 2018 Option Exercise$4.173,77615,74612,176Jun 18, 2018, 10:19 AM
Malik RajeshCh. Medical Officer & SVP R&DJun 15, 2018 Sale$44.313,776167,3268,400Jun 18, 2018, 10:19 AM
Malik RajeshCh. Medical Officer & SVP R&DJun 08, 2018 Option Exercise$0.394,2001,6388,400Jun 11, 2018, 10:51 AM
Moses Jennifer K.VP of Finance & AdminJun 05, 2018 Option Exercise$0.39750292750Jun 05, 2018, 02:23 PM
Moses Jennifer K.VP of Finance & AdminJun 05, 2018 Sale$38.7775029,0780Jun 05, 2018, 02:23 PM
Thorp Clay10% OwnerMay 30, 2018 Sale$48.00800,00038,400,0003,279,421Jun 01, 2018, 06:22 PM
Velleca Mark A.President and CEOMay 31, 2018 Option Exercise$0.3910,0003,90010,000May 31, 2018, 04:22 PM
Thorp Clay10% OwnerMay 23, 2018 Sale$50.5050025,2504,037,737May 23, 2018, 08:46 PM
Thorp Clay10% OwnerMay 22, 2018 Sale$50.855,900300,0164,038,519May 23, 2018, 08:46 PM
Thorp Clay10% OwnerMay 21, 2018 Sale$51.1731,1001,591,4114,046,206May 23, 2018, 08:46 PM
Velleca Mark A.President and CEOMay 15, 2018 Option Exercise$3.727,50027,9007,500May 16, 2018, 01:37 PM
Velleca Mark A.President and CEOMay 15, 2018 Sale$46.287,500347,0641,700May 16, 2018, 01:37 PM
Malik RajeshCh. Medical Officer & SVP R&DMay 15, 2018 Option Exercise$4.173,77615,7467,976May 16, 2018, 01:37 PM
Malik RajeshCh. Medical Officer & SVP R&DMay 15, 2018 Sale$46.303,776174,8214,300May 16, 2018, 01:37 PM
Moses Jennifer K.VP of Finance & AdminMay 07, 2018 Option Exercise$0.39750292750May 07, 2018, 03:04 PM
Moses Jennifer K.VP of Finance & AdminMay 07, 2018 Sale$45.0075033,7500May 07, 2018, 03:04 PM
Velleca Mark A.President and CEOApr 16, 2018 Option Exercise$3.727,50027,9007,500Apr 17, 2018, 12:20 PM
Velleca Mark A.President and CEOApr 16, 2018 Sale$36.007,500269,971500Apr 17, 2018, 12:20 PM
Malik RajeshCh. Medical Officer & SVP R&DApr 16, 2018 Option Exercise$4.173,77615,7467,976Apr 17, 2018, 12:20 PM
Malik RajeshCh. Medical Officer & SVP R&DApr 16, 2018 Sale$36.053,776136,1354,700Apr 17, 2018, 12:20 PM
Moses Jennifer K.VP of Finance & AdminApr 05, 2018 Option Exercise$0.39750292750Apr 05, 2018, 04:04 PM
Moses Jennifer K.VP of Finance & AdminApr 05, 2018 Sale$37.4775028,1030Apr 05, 2018, 04:04 PM
Velleca Mark A.President and CEOMar 15, 2018 Option Exercise$3.727,50027,9007,500Mar 16, 2018, 10:09 AM
Velleca Mark A.President and CEOMar 15, 2018 Sale$38.207,500286,4660Mar 16, 2018, 10:09 AM
Malik RajeshCh. Medical Officer & SVP R&DMar 15, 2018 Option Exercise$0.893,7763,3487,976Mar 16, 2018, 10:09 AM
Malik RajeshCh. Medical Officer & SVP R&DMar 15, 2018 Sale$38.183,776144,1514,200Mar 16, 2018, 10:09 AM
Malik RajeshCh. Medical Officer & SVP R&DMar 08, 2018 Option Exercise$0.394,2001,6384,200Mar 09, 2018, 02:36 PM
Moses Jennifer K.VP of Finance & AdminMar 05, 2018 Option Exercise$0.39750292750Mar 06, 2018, 04:01 PM
Moses Jennifer K.VP of Finance & AdminMar 05, 2018 Sale$26.5575019,9120Mar 06, 2018, 04:01 PM
Velleca Mark A.President and CEOFeb 15, 2018 Option Exercise$3.727,50027,9007,500Feb 16, 2018, 11:54 AM
Velleca Mark A.President and CEOFeb 15, 2018 Sale$20.007,500150,0150Feb 16, 2018, 11:54 AM
Malik RajeshCh. Medical Officer & SVP R&DFeb 15, 2018 Option Exercise$0.323,7761,2133,776Feb 16, 2018, 11:54 AM
Malik RajeshCh. Medical Officer & SVP R&DFeb 15, 2018 Sale$20.003,77675,5200Feb 16, 2018, 11:54 AM
Moses Jennifer K.VP of Finance & AdminFeb 05, 2018 Option Exercise$0.39750292750Feb 06, 2018, 11:00 AM
Moses Jennifer K.VP of Finance & AdminFeb 05, 2018 Sale$22.9975017,2420Feb 06, 2018, 11:00 AM
Velleca Mark A.President and CEOJan 16, 2018 Option Exercise$3.727,50027,9007,500Jan 17, 2018, 09:48 AM
Velleca Mark A.President and CEOJan 16, 2018 Sale$22.997,500172,3950Jan 17, 2018, 09:48 AM
Malik RajeshCh. Medical Officer & SVP R&DJan 16, 2018 Option Exercise$0.303,7761,1333,776Jan 17, 2018, 09:47 AM
Malik RajeshCh. Medical Officer & SVP R&DJan 16, 2018 Sale$22.963,77686,6930Jan 17, 2018, 09:47 AM
Moses Jennifer K.VP of Finance & AdminJan 05, 2018 Option Exercise$0.39750292750Jan 08, 2018, 09:42 AM
Moses Jennifer K.VP of Finance & AdminJan 05, 2018 Sale$19.9675014,9700Jan 08, 2018, 09:42 AM
Velleca Mark A.President and CEODec 18, 2017 Option Exercise$3.727,50027,9007,500Dec 20, 2017, 08:48 AM
Velleca Mark A.President and CEODec 18, 2017 Sale$20.017,500150,1060Dec 20, 2017, 08:48 AM
MedImmune Ventures, Inc.10% OwnerDec 15, 2017 Sale$19.75200,0003,950,0002,950,630Dec 18, 2017, 05:48 PM
MedImmune Ventures, Inc.10% OwnerMay 17, 2017 Buy$15.0075,0001,125,0003,409,536Dec 13, 2017, 11:46 AM
MedImmune Ventures, Inc.10% OwnerDec 01, 2017 Sale$19.75133,9062,644,6443,150,630Dec 05, 2017, 09:17 AM
MedImmune Ventures, Inc.10% OwnerNov 20, 2017 Sale$20.01200,0004,002,0003,284,536Nov 22, 2017, 10:13 AM
ESHELMAN FREDRIC NDirectorNov 13, 2017 Buy$19.73250,0004,932,500250,000Nov 15, 2017, 05:12 PM
Eshelman Ventures, LLC10% OwnerMay 22, 2017 Buy$15.00300,0004,500,0003,439,151May 24, 2017, 08:29 PM
Thorp Clay10% OwnerMay 22, 2017 Buy$15.00133,3331,999,9953,861,797May 24, 2017, 08:18 PM
ESHELMAN FREDRIC NDirectorMay 22, 2017 Buy$15.00300,0004,500,0003,439,151May 24, 2017, 08:05 PM
MUIR GLENN PDirectorMay 22, 2017 Buy$15.0020,000300,000120,969May 24, 2017, 07:58 PM
MedImmune Ventures, Inc.10% OwnerMay 22, 2017 Buy$15.0075,0001,125,0003,484,536May 24, 2017, 07:57 PM
RA CAPITAL MANAGEMENT, LLCFmr 10% Owner See Footnote (2)May 22, 2017 Buy$15.00400,0006,000,0002,684,244May 24, 2017, 04:34 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Moses Jennifer K.CFO01/05/20233,942
Moses Jennifer K.CFO01/04/20239,138
MURDOCK TERRY LChief Operating Officer01/05/20233,942
MURDOCK TERRY LChief Operating Officer01/04/20239,138
Perry AndrewChief Commercial Officer01/04/20234,572
Malik RajeshChief Medical Officer01/05/20233,942
Malik RajeshChief Medical Officer01/04/20239,138
Hanson James S.General Counsel01/05/20233,942
Hanson James S.General Counsel01/04/20239,138
Bailey John E. (Jack) Jr.President and CEO01/04/202331,262
Bailey John E. (Jack) Jr.President and CEO01/03/2023187,452
Malik RajeshChief Medical Officer12/15/20224,200
Velleca Mark A.Director10/18/20225,850
Velleca Mark A.Director10/18/2022175,489
Velleca Mark A.Director09/20/20227,800
Velleca Mark A.Director09/20/2022270,044
Malik RajeshChief Medical Officer09/13/20227,020
Malik RajeshChief Medical Officer09/13/2022282,746
Velleca Mark A.Director08/16/202231,200
Velleca Mark A.Director08/16/20221,010,904
Velleca Mark A.Director02/07/20225,850
Moses Jennifer K.CFO02/01/20229,579
Malik RajeshChief Medical Officer02/01/20223,000
Hanson James S.General Counsel01/05/202215,334
MURDOCK TERRY LChief Operating Officer01/05/202215,334
Moses Jennifer K.CFO01/05/202215,334
Malik RajeshChief Medical Officer01/05/202215,334
Avagliano MarkChief Business Officer01/05/202215,334
Bailey John E. (Jack) Jr.President and CEO01/03/2022355,262
Velleca Mark A.Director11/09/202115,600
Velleca Mark A.Director07/15/20213,900
Velleca Mark A.Director07/14/20213,900
Velleca Mark A.Director07/13/20213,900
Velleca Mark A.Director07/14/2021190,824
Velleca Mark A.Director07/13/2021194,536
Velleca Mark A.Director07/15/2021184,898
RUDNICK SETHDirector06/29/20213,717
RUDNICK SETHDirector06/29/2021223,477
Velleca Mark A.Director06/17/20213,900
Velleca Mark A.Director06/16/20213,900
Velleca Mark A.Director06/15/20213,900
Velleca Mark A.Director06/17/2021217,728
Velleca Mark A.Director06/16/2021217,384
Velleca Mark A.Director06/15/2021223,909
Velleca Mark A.Director05/25/20217,800
Malik RajeshChief Medical Officer04/22/20215,850
Malik RajeshChief Medical Officer04/22/2021331,099
Malik RajeshChief Medical Officer03/23/20215,850
Malik RajeshChief Medical Officer03/23/2021329,059
Malik RajeshChief Medical Officer03/02/202123,219
Malik RajeshChief Medical Officer03/02/2021344,192
Moses Jennifer K.CFO03/03/202111,160
Velleca Mark A.Director02/16/202141,069
Velleca Mark A.Director02/18/202137,200
Velleca Mark A.Director02/17/202137,200
Velleca Mark A.Director02/16/2021388,653
Velleca Mark A.Director02/18/2021260,152
Velleca Mark A.Director02/17/2021276,433
Malik RajeshChief Medical Officer01/27/20211,209
Malik RajeshChief Medical Officer01/22/202162,550
Malik RajeshChief Medical Officer01/22/2021309,591
Velleca Mark A.Director01/20/202138,760
Velleca Mark A.Director01/19/202137,200
Velleca Mark A.Director01/21/202137,200
Velleca Mark A.Director01/20/2021215,107
Velleca Mark A.Director01/19/2021208,781
Velleca Mark A.Director01/21/2021206,400
RUDNICK SETHDirector12/24/202018,572
RUDNICK SETHDirector12/22/2020385,702
RUDNICK SETHDirector12/23/2020264,757
Velleca Mark A.President and CEO12/17/202037,200
Velleca Mark A.President and CEO12/16/202037,200
Velleca Mark A.President and CEO12/15/202037,200
Velleca Mark A.President and CEO12/17/2020199,668
Velleca Mark A.President and CEO12/16/2020192,021
Velleca Mark A.President and CEO12/15/2020194,297
Malik RajeshCh. Medical Officer & SVP R&D12/10/202037,530
Malik RajeshCh. Medical Officer & SVP R&D12/10/2020180,550
RUDNICK SETHDirector12/10/202010,921
RUDNICK SETHDirector12/09/2020117,284
RUDNICK SETHDirector12/08/2020265,694
RUDNICK SETHDirector12/01/202010,449
MUIR GLENN PDirector11/18/2020675,000
Bailey John E. (Jack) Jr.Director11/11/202051,320
Bailey John E. (Jack) Jr.Director11/10/202051,055
Hanson James S.General Counsel09/04/202014,950
Moses Jennifer K.CFO03/13/20207,440
Malik RajeshCh. Medical Officer & SVP R&D03/13/2020975
Velleca Mark A.President and CEO03/13/20201,170
Velleca Mark A.President and CEO01/23/20202,340
Moses Jennifer K.CFO01/23/20203,720
Malik RajeshCh. Medical Officer & SVP R&D01/23/20201,950
Moses Jennifer K.CFO07/18/20197,440
Malik RajeshCh. Medical Officer & SVP R&D01/28/20192,730
Moses Jennifer K.VP of Finance01/17/20197,440
Velleca Mark A.President and CEO01/17/20193,510
Strum JayChief Scientific Officer01/02/201927,575
Hanson James S.General Counsel12/26/201818,250
Schwalm CynthiaDirector12/26/201826,196
Malik RajeshCh. Medical Officer & SVP R&D12/17/201815,746
Malik RajeshCh. Medical Officer & SVP R&D12/17/2018113,280
Hanson James S.General Counsel12/10/201832,508
DEMAREE JOHNChief Commercial Officer12/10/201833,151
Moses Jennifer K.VP of Finance & Admin12/07/20187,440
Moses Jennifer K.VP of Finance & Admin12/06/2018292
Moses Jennifer K.VP of Finance & Admin12/06/201825,500
RUDNICK SETHDirector12/04/20183,900
RUDNICK SETHDirector12/04/2018393,146
MURDOCK TERRY LSVP of Development Operations12/03/201847,596
MURDOCK TERRY LSVP of Development Operations12/03/2018135,779
PHILLIPS BARCLAY ASVP & Chief Financial Officer11/15/201897,300
PHILLIPS BARCLAY ASVP & Chief Financial Officer11/15/2018199,591
Velleca Mark A.President and CEO11/15/201818,600
Velleca Mark A.President and CEO11/15/2018199,211
Malik RajeshCh. Medical Officer & SVP R&D11/15/201815,746
Malik RajeshCh. Medical Officer & SVP R&D11/15/2018150,105
RUDNICK SETHDirector11/05/20183,900
RUDNICK SETHDirector11/05/2018415,347
MURDOCK TERRY LSVP of Development Operations11/05/201847,542
MURDOCK TERRY LSVP of Development Operations11/05/2018146,129
Moses Jennifer K.VP of Finance & Admin11/05/2018292
Moses Jennifer K.VP of Finance & Admin11/05/201831,035
Malik RajeshCh. Medical Officer & SVP R&D10/15/201818,203
Malik RajeshCh. Medical Officer & SVP R&D10/15/2018157,497
Velleca Mark A.President and CEO10/11/20183,900
Velleca Mark A.President and CEO10/15/201818,600
Velleca Mark A.President and CEO10/15/2018207,645
Moses Jennifer K.VP of Finance & Admin10/08/2018292
Moses Jennifer K.VP of Finance & Admin10/08/201833,390
Strum JayChief Scientific Officer10/04/2018255
RUDNICK SETHDirector10/04/20183,900
RUDNICK SETHDirector10/04/2018497,210
MURDOCK TERRY LSVP of Development Operations10/03/201847,542
MURDOCK TERRY LSVP of Development Operations10/03/2018173,064
Velleca Mark A.President and CEO09/17/201818,600
Velleca Mark A.President and CEO09/17/2018331,549
Malik RajeshCh. Medical Officer & SVP R&D09/17/201815,746
Malik RajeshCh. Medical Officer & SVP R&D09/17/2018249,502
Moses Jennifer K.VP of Finance & Admin09/05/20187,733
Moses Jennifer K.VP of Finance & Admin09/05/201844,700
RUDNICK SETHDirector09/04/20183,900
RUDNICK SETHDirector09/04/2018599,483
MURDOCK TERRY LSVP of Development Operations09/04/201847,542
MURDOCK TERRY LSVP of Development Operations09/04/2018211,065
Strum JayChief Scientific Officer08/30/2018299,876
Strum JayChief Scientific Officer08/29/2018296,095
Malik RajeshCh. Medical Officer & SVP R&D08/15/201815,746
Malik RajeshCh. Medical Officer & SVP R&D08/15/2018211,023
Velleca Mark A.President and CEO08/15/201818,600
Velleca Mark A.President and CEO08/15/2018279,378
RUDNICK SETHDirector08/06/20183,900
RUDNICK SETHDirector08/06/2018506,901
Moses Jennifer K.VP of Finance & Admin08/06/2018292
Moses Jennifer K.VP of Finance & Admin08/06/201838,093
MURDOCK TERRY LSVP of Development Operations08/03/201847,542
MURDOCK TERRY LSVP of Development Operations08/03/2018178,061
Malik RajeshCh. Medical Officer & SVP R&D07/16/201815,746
Malik RajeshCh. Medical Officer & SVP R&D07/16/2018159,248
Velleca Mark A.President and CEO07/16/201818,600
Velleca Mark A.President and CEO07/16/2018210,313
Moses Jennifer K.VP of Finance & Admin07/05/2018292
Moses Jennifer K.VP of Finance & Admin07/05/201834,245
Malik RajeshCh. Medical Officer & SVP R&D06/15/201815,746
Malik RajeshCh. Medical Officer & SVP R&D06/15/2018167,326
Malik RajeshCh. Medical Officer & SVP R&D06/08/20181,638
Moses Jennifer K.VP of Finance & Admin06/05/2018292
Moses Jennifer K.VP of Finance & Admin06/05/201829,078
Thorp Clay10% Owner05/30/201838,400,000
Velleca Mark A.President and CEO05/31/20183,900
Thorp Clay10% Owner05/23/201825,250
Thorp Clay10% Owner05/22/2018300,016
Thorp Clay10% Owner05/21/20181,591,411
Velleca Mark A.President and CEO05/15/201827,900
Velleca Mark A.President and CEO05/15/2018347,064
Malik RajeshCh. Medical Officer & SVP R&D05/15/201815,746
Malik RajeshCh. Medical Officer & SVP R&D05/15/2018174,821
Moses Jennifer K.VP of Finance & Admin05/07/2018292
Moses Jennifer K.VP of Finance & Admin05/07/201833,750
Velleca Mark A.President and CEO04/16/201827,900
Velleca Mark A.President and CEO04/16/2018269,971
Malik RajeshCh. Medical Officer & SVP R&D04/16/201815,746
Malik RajeshCh. Medical Officer & SVP R&D04/16/2018136,135
Moses Jennifer K.VP of Finance & Admin04/05/2018292
Moses Jennifer K.VP of Finance & Admin04/05/201828,103
Velleca Mark A.President and CEO03/15/201827,900
Velleca Mark A.President and CEO03/15/2018286,466
Malik RajeshCh. Medical Officer & SVP R&D03/15/20183,348
Malik RajeshCh. Medical Officer & SVP R&D03/15/2018144,151
Malik RajeshCh. Medical Officer & SVP R&D03/08/20181,638
Moses Jennifer K.VP of Finance & Admin03/05/2018292
Moses Jennifer K.VP of Finance & Admin03/05/201819,912
Velleca Mark A.President and CEO02/15/201827,900
Velleca Mark A.President and CEO02/15/2018150,015
Malik RajeshCh. Medical Officer & SVP R&D02/15/20181,213
Malik RajeshCh. Medical Officer & SVP R&D02/15/201875,520
Moses Jennifer K.VP of Finance & Admin02/05/2018292
Moses Jennifer K.VP of Finance & Admin02/05/201817,242
Velleca Mark A.President and CEO01/16/201827,900
Velleca Mark A.President and CEO01/16/2018172,395
Malik RajeshCh. Medical Officer & SVP R&D01/16/20181,133
Malik RajeshCh. Medical Officer & SVP R&D01/16/201886,693
Moses Jennifer K.VP of Finance & Admin01/05/2018292
Moses Jennifer K.VP of Finance & Admin01/05/201814,970
Velleca Mark A.President and CEO12/18/201727,900
Velleca Mark A.President and CEO12/18/2017150,106
MedImmune Ventures, Inc.10% Owner12/15/20173,950,000
MedImmune Ventures, Inc.10% Owner05/17/20171,125,000
MedImmune Ventures, Inc.10% Owner12/01/20172,644,644
MedImmune Ventures, Inc.10% Owner11/20/20174,002,000
ESHELMAN FREDRIC NDirector11/13/20174,932,500
Eshelman Ventures, LLC10% Owner05/22/20174,500,000
Thorp Clay10% Owner05/22/20171,999,995
ESHELMAN FREDRIC NDirector05/22/20174,500,000
MUIR GLENN PDirector05/22/2017300,000
MedImmune Ventures, Inc.10% Owner05/22/20171,125,000
RA CAPITAL MANAGEMENT, LLCFmr 10% Owner See Footnote (2)05/22/20176,000,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2022
06/30/2022
0.08%
1Q
09/30/2022
12/31/2021
1.88%
3Q
09/30/2022
06/30/2021
3.18%
5Q
09/30/2022
03/31/2021
4.99%
6Q
09/30/2022
12/31/2020
12.81%
7Q
09/30/2022
09/30/2020
12.99%
8Q
09/30/2022
06/30/2020
13.28%
9Q
09/30/2022
03/31/2020
13.47%
10Q
09/30/2022
12/31/2019
13.95%
11Q
09/30/2022
09/30/2019
14.04%
12Q
09/30/2022
06/30/2019
14.15%
13Q
09/30/2022
03/31/2019
14.27%
14Q
09/30/2022
09/30/2018
33.51%
16Q
Load More

Period of Report: 09/30/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2022
0.08%
1Q
12/31/2021
1.88%
3Q
06/30/2021
3.18%
5Q
03/31/2021
4.99%
6Q
12/31/2020
12.81%
7Q
09/30/2020
12.99%
8Q
06/30/2020
13.28%
9Q
03/31/2020
13.47%
10Q
12/31/2019
13.95%
11Q
09/30/2019
14.04%
12Q
06/30/2019
14.15%
13Q
03/31/2019
14.27%
14Q
09/30/2018
33.51%
16Q
Load More